Outcome of the Board Meeting - Appointment of Company Secretary and Compliance Officer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Ltd's Board of Directors, at a meeting held on January 30, 2026, approved the appointment of Ms. Pooja Kothari (ACS Membership No. A64463) as the Company's Secretary and Compliance Officer, effective the same day. Ms. Kothari is an Associate Member of the Institute of Company Secretaries of India (ICSI), qualified since December 2019, and brings about 4 years of experience in company law and secretarial compliance with private and unlisted public companies. She is not related to any existing Directors or Key Managerial Personnel of the company, and has not been debarred from holding the position by any authority. The board meeting ran from 6:30 PM to 7:00 PM.
This is a routine compliance-related appointment that fills a key managerial position required under SEBI listing rules. It is a positive housekeeping signal but unlikely to materially affect the stock price or shareholder value.